Position in AUPH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,114,861
-$3,650,761 QoQ
Shares Held
65,696
-79.6% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 279 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Derivatives in AUPH
reported options exposure · as of Jun 30, 2026CallValue
$123,881
CallShares
7,300
PutValue
$283,399
PutShares
16,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. AUPH ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in AUPH
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,881 | 7,300 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $283,399 | 16,700 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $1,114,861 | 65,696 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $62,244 | 4,200 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $4,765,622 | 321,567 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $454,974 | 30,700 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $1,212,200 | 76,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $365,334 | 22,905 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $405,130 | 25,400 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $12,155 | 1,100 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $286,195 | 25,900 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $70,642 | 6,393 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $60,137 | 7,100 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $44,408 | 5,243 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $95,711 | 11,300 | Put | Sole | 2025-08-13 | |
| 2025-03-31 | $118,992 | 14,800 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $37,088 | 4,613 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $70,752 | 8,800 | Put | Sole | 2025-05-14 | |
| 2024-12-31 | $269,400 | 30,000 | Put | Sole | 2025-02-13 | |
| 2024-12-31 | $397,814 | 44,300 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $201,575 | 27,500 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $371,631 | 50,700 | Call | Sole | 2024-11-14 | |
| 2024-03-31 | $6,407 | 1,279 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $88,677 | 17,700 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $20,541 | 4,100 | Put | Sole | 2024-05-15 | |
| 2022-12-31 | $4,320 | 1,000 | Put | Sole | 2023-02-14 | |
| 2022-12-31 | $355,298 | 82,245 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $4,320 | 1,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $15,040 | 2,000 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $2,231,244 | 296,708 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $7,520 | 1,000 | Call | Sole | 2022-11-14 | |
| 2022-03-31 | $428,174 | 34,586 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||